Immune composition comprising antigen and glycoengineered antibody thereof
US12171824B2 · kind B2 · utility
0Cited by
2References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 5, 2021 |
| Grant date | Dec 24, 2024 |
| Priority date | — |
| Expiry date | Sep 3, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2770/20034
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to a composition for inducing immune response comprising a glycoengineered antibody or antigen-binding fragment thereof that is specific for an antigen portion having a receptor binding domain (RBD) of a surface protein of a virus. The present disclosure also relates to an immune combination and a method for treating an infection by a virus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.